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ABSTRACT 
 
EXPLORING VARIABLES OF POST-OPERATIVE DEPRESSION  
IN CARDIAC SURGICAL PATIENTS 
 
 
 
By 
Mary Malitas 
December 2016 
 
Dissertation supervised by Dr. Kathleen Sekula 
 Evidence supports that both psychological and psychosocial factors, such as 
uncertainty and depression contribute to the incidence of poor health outcomes in cardiac 
patients undergoing surgery.  Uncertainty and depression can illicit feelings of loss of 
control and have a direct effect on the health related quality of life of patients undergoing 
cardiac surgery.  Known predictor variables were identified and proposals for further 
research were explored in order to establish a standard of care for this population related 
to their psychological health.  This research attempts to highlight those variables that 
impact the long-term outcomes of cardiac patients.  In addition, the role of serotonin 
levels is explored as a function of identifying depressive symptomatology before and 
after surgery.  Pre-operative assessment of these variables may assist in the development 
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of interventional strategies that can be applied by health care providers in order to 
identify those patients at risk and to ultimately improve health outcomes.  
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CHAPTER ONE 
Introduction 
 
Coronary artery bypass grafting (CABG) surgery is the recognized treatment for 
those patients with symptoms of ischemic heart disease identified through coronary 
angiography not amenable to percutaneous intervention.  The goals of the surgery are 
related to reducing morbidity and mortality from future coronary risk factors, improve 
quality of life, and prolong life expectancy (Hawkes, Nowak, Bidstrup, & Speare, 2006; 
McKenzie, Simpson, & Stewart, 2010).  Through the literature, there is corroboration that 
psychosocial factors including those of uncertainty and depression contribute to the 
development of depressive symptomology.  These factors along with a sense of loss of 
control have a direct effect on the individual's health related quality of life.   
Psychological distress manifested by feelings of uncertainty and symptoms of 
depression have been reported as pre-operative correlates affecting health outcomes after 
surgery (Fitzsimons, Parahoo, & Stringer, 2000; Koivula, Tarkka, Tarkka, Laippala, & 
Paunonen-Ilmonen, 2002; McCormick, Naimark, & Tate, 2006) .  "Better understanding 
of the mood predictors, such as depression and anxiety, should help the identification and 
treatment of at- risk patients in this clinical population"  (McKenzie et al., 2010, p. 75). In 
addition, a review of the literature examined the function of serotonin as a 
neurotransmitter in the body.   Its correlation to depressive symptoms is not fully 
understood and warrants further exploration and assessment in this population (Elder & 
Mosack, 2011; Lacasse & Leo, 2005; Lemonick, 1997; Wankerl, Wust, & Otte, 2010). 
Presently, most health care clinicians do not perform a focused assessment of the 
patient related to their psychological well-being with consideration to factors that could 
influence their recovery.  Within the cardiac surgery population, there is no established 
  2 
standard of care or core measure that assesses pre-cardiac surgery patients who are at risk 
for depression post-surgery.    
The objective of this research inquiry was to evaluate associative factors in the 
pre-operative phase that could potentiate post-operative depression.  Specifically, the 
research examined the influence among uncertainty and serotonin levels on post-
operative depressive symptomology. This information demonstrated the need for 
development of future research into interventional strategies by health care clinicians to 
optimize patient outcomes.  
The aim of the research was the investigation of pre-operative uncertainty, 
depression, and serotonin levels as associative factors of post-operative depression in the 
cardiac surgical population. Specifically, this inquiry explored the relationship between a 
pre-operative serotonin level, levels of uncertainty using Mishel's Uncertainty in Illness 
Scale (MUIS), and depressive symptomatology measured by Beck's Depression 
Inventory (BDI) as associative (predictive) factors in post-operative depression. 
The long-term goal of this research would be to establish standards of practice 
based on the findings in order to provide guidelines for assessment, prevention and 
treatment in caring for patients undergoing cardiac surgery in order to lessen the negative 
impact of depression post surgically. The results of this inquiry support the call for 
research related to nursing strategies to guide practice, affect pre-operative teaching to 
the patient, and improve postoperative outcomes.  The development of evidence-based 
practice will change the delivery of care. 
The research questions that were addressed are:  
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1. What is the relationship between selected demographic variables and post-
operative depression in a cardiac patient undergoing surgery? 
2. What is the relationship between pre-operative serotonin levels and depression 
scores measured pre-operatively (Time 1), at 4 weeks post-operatively (Time 2), 
and at 12 weeks post-operatively (Time 3)?  
3.  What is the relationship between scores on the Beck Depression Inventory 
compared pre-operatively and post-operatively in the cardiac surgical patient? 
4. What is the relationship between scores on the Mishel Uncertainty in Illness Scale 
in comparison to scores on the Beck Depression Inventory pre-operatively, at 4 
weeks, and at 12 weeks post-operatively? 
5. Is a combination of selected socio-demographic variables, pre-operative serotonin 
level, uncertainty, and depression scores a predictor of post-operative depression 
at 4 weeks and 12 weeks post-operatively? 
Background and Significance 
 
The investigation of uncertainty, depression, and their clinical sequelae in the 
cardiac surgical participants in this study focused on pre-operative evaluation with follow 
up during the post-operative course.   Research in cardiac surgical patients demonstrated 
that post-operative depression is linked with an increase in morbidity, mortality, and 
l increased readmissions for cardiac events (Blumenthal, et al., 2003; Oxlad, 
Stubberfield, Stuklis, Edwards, & Wade, 2006; Tully & Szackely, 2013). In addressing 
potential causes of depression, the effect of serotonin, a neurotransmitter, emerged as a 
potential correlate to symptoms of depression.  Much of the research related to serotonin 
as a direct contributor has been controversial; centered mainly on therapeutic treatment 
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options after the diagnosis. The role serotonin levels may play in identifying those 
individuals at greater risk for depression related to illness or surgery is worthy of further 
exploration.  A review of the literature examined the function of serotonin as a 
neurotransmitter in the body as well as associated research studies that have investigated 
the measurement of serotonin levels and depressive symptoms within cardiac disease 
processes (Lett et al., 2004; Meltzer, 1989; Sanner & Frazier, 2011) 
Current literature described a relationship between post-operative psychological 
status and recovery in the cardiac patient (Blumenthal et al., 2003; Mallik et al., 2005; 
Pignay-Demaria, Lesperance, Demaria, Frasure-Smith, & Perrault, 2003).  This research 
was conducted to explore the relationship between cardiac surgery and depression, along 
with potential predictor variables that may assist in the development of standards of 
health care practices for patients undergoing cardiac revascularization.   
Theoretical Framework 
The mid-range theoretical framework developed by Mishel guided this research 
study. The uncertainty in illness theory explains how a patient deals with illness related 
events and their outcomes. The theory is based on three themes, antecedents of 
uncertainty, which includes stimuli frame, cognitive capacities, and structure providers. 
These subtexts refer to how stimuli is perceived, information processed, and how outside 
support affects the patient in either a positive or a negative direction. Appraisal of 
uncertainty includes inference and illusion, which describes an evaluative process of 
uncertainty, based on personal experiences, knowledge, and constructed beliefs affecting 
outlook.  Lastly, coping with uncertainty includes the concepts of danger, opportunity, 
coping and adaptation (Mishel, 1981, 1988; Mishel & Clayton, 2008). Each of these 
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processes influences the evolution of uncertainty into a positive or negative outcome.  
The uncertainty in illness theory highlights the process a patient may experience when 
dealing with either an acute illness or a chronic condition. 
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CHAPTER TWO 
Chapter 2 includes the first manuscript. A thorough review of the literature was 
conducted and the manuscript was written to meet the requirements for the target journal. 
The manuscript was submitted, reviewed by the editorial board reviewers, and revisions 
are currently in process for resubmission.  
Manuscript 1 
Introduction 
 
Coronary artery bypass grafting (CABG) surgery is the recognized treatment for 
those patients with symptoms of ischemic heart disease identified through coronary 
angiography not amenable to percutaneous intervention.  The goals of the surgery are to 
reduce morbidity and mortality from coronary risk factors, improve quality of life, and 
prolong life expectancy (Hawkes et al., 2006; McKenzie et al., 2010).   The literature 
clearly provides evidence that both psychological and psychosocial factors including 
those of uncertainty and depression may contribute to the incidence of poor health 
outcomes in this population (McCormick et al., 2006; White & Frasure-Smith, 1995).  
Uncertainty and depression can illicit feelings associated with a loss of control and have a 
direct effect on the health related quality of life beginning in the pre-operative phase and 
often continuing through the post-operative state (Fitzsimons et al., 2000; Gallagher & 
McKinley, 2009; So & La Guardia, 2011).   
Psychological distress manifested by symptoms related to uncertainty and 
depression have been reported as pre-operative correlates affecting health outcomes after 
cardiac surgery and coronary angioplasty (Fitzsimons et al., 2000; Koivula et al., 2002; 
McCormick et al., 2006).  Recognition of these psychological risk factors may assist the 
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clinician with early identification of patients at risk for depression within the cardiac 
surgical population (McKenzie et al., 2010).  
This review explored the role of preoperative uncertainty and depression on 
quality of life in patients with coronary artery disease.  Evidence of the negative effects 
of post-operative depression including an increase in morbidity, mortality, and 
readmissions for cardiac events was addressed (Blumenthal et al., 2003; Oxlad et al., 
2006; Tully, Baker, Turnbull, Winefield, & Knight, 2009).  An assessment of the patient 
and their psychological wellbeing with consideration of factors that may influence 
recovery in the post-operative period was reviewed.  An examination of the role of 
serotonin, a neurotransmitter, which is often cited relative to depression, may assist to 
correlate findings with those of uncertainty and depression. This review examined the 
current state of science regarding the relationship between depression, uncertainty, 
serotonin, and patients undergoing cardiac surgery.  The lack of pre-surgical assessment, 
which may result in negative health outcomes, presents a need for further research and 
evaluation of pre-operative psychological and psychosocial well-being in this population. 
Cardiac Surgery and Depression 
 
William Harvey, in 1628, first suggested the link between the "mind and the 
heart" in describing both positive and negative emotions with their correlational effects 
on the heart (Rumsfeld & Ho, 2005).  However, it was not until over three centuries later 
that research studies began to establish sound evidence for this relationship.  It was first 
reported in the 1980's that a relationship existed between cardiovascular patients with 
major depression and the increased risk of cardiovascular events, leading to major cardiac 
surgery, and increased mortality rates (Peterson et al., 2002).  
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The varying etiologies of post-operative depression include reports of anxiety, 
stress of cardiac surgery and patient co-morbidities (Hawkes et al., 2006; Timberlake et 
al., 1997).  Researchers have reported pre-operative depression as a predictor of negative 
psychological effect in the post-operative phase.  Similar results were found among pre-
operative depression scores and quality of life scores after cardiac surgery (Mallik et al., 
2005; Peterson et al., 2002; Timberlake et al., 1997; Tully et al., 2009).   
 In the early 1980's, Merle Mishel developed a theory related to uncertainty in 
illness and its effect on the overall well-being of the individual.  Her initial work in 
uncertainty was influenced by the work of Lazarus (1974) on stress and coping.  Further 
guided by the work of Bower (1978) and Shalit (1977), Mishel continued to investigate 
the importance of the cognitive state in stress response (Mishel & Clayton, 2008; Smith 
& Liehr, 2008).   The theory of uncertainty in illness consists of three major themes that 
include antecedents of uncertainty, how past illness experiences affect patient ability to 
deal with present situation;” appraisal of uncertainty, which places value on present 
uncertainty, and coping with uncertainty for adaptation. (Mishel, 1981, 1988; Mishel & 
Clayton, 2008).  
 Personal experiences reflect behaviors exhibited as coping mechanisms to control 
environmental stimuli in terms of a diagnosis of acute illness or living with a chronic, 
sometimes life-threatening illness.  Mishel defined uncertainty as an "inability to 
determine the meaning of illness-related events, occurring when the decision maker…  is 
unable to predict outcomes accurately" (Alligood & Tomey, 2010, p. 601).  This 
definition highlights the interpretation and understanding of the diagnosis by the 
individual. Mishel offers an assessment of cognitive aspects of uncertainty based on the 
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individual's inherent nature, exposure to previous stimuli, and their outcomes.  She 
utilizes the terms danger or opportunity to evaluate whether a person demonstrates a 
positive or negative response to uncertainty as an indicator of each person's capacity for 
adaptation to illness (Mishel, 1988).  Her research revealed the effects of uncertainty in 
many different disease populations including those with cardiac disease (Eastwood, 
Doering, Roper, & Hays, 2008; McCormick et al., 2006; White & Frasure-Smith, 1995).   
In 2006, McCormick and colleagues conducted a cross-sectional, descriptive, 
correlational study investigating both psychological and physical factors influencing 
patients awaiting a cardiac surgical procedure. In this study, the theoretical framework of 
Mishel's Uncertainty in Illness provided the guiding principles in describing the manner 
in which patients assimilate information and develop an understanding of their illness. In 
this mixed methods study, forty-two patients were assessed for levels of uncertainty 
(Mishel's Uncertainty in Illness Scale), anxiety (Graphical Anxiety Rating Scale), 
symptom distress (symptoms frequency and symptom distress Scale), and functional 
status (Kansas City Cardiomyopathy Questionnaire Subscales).  In addition, the influence 
of length of time waiting for surgery on psychosomatic condition was explored.  Of those 
forty-two patients, twenty-six agreed to be interviewed regarding their experience while 
waiting for surgery.   
The data revealed that length of time awaiting surgery and its effect on 
psychological factors did not reach statistical significance; however, based on interviews, 
responses, and extrapolated themes, the investigators concluded that patients experienced 
both positive and negative feelings based on the patient response at a particular moment. 
Highly significant correlations were found between functional status and anxiety, 
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symptom distress, and physical limitations.  While no significant differences were 
observed between the length of time (<2 months, 2-4 months, and > 4 months), symptom 
frequency scores and anxiety, levels tended to increase with time along with a 
deterioration of social and physical functional status as waiting time increased.   Findings 
suggest that regular assessment of symptoms and functional status during the waiting 
period may help to stabilize the patient's cardiac status.  The researchers recommend that 
further research be conducted in a larger sample in a time series including both pre-
operative and post-operative phases of care.  This study highlighted the benefit of 
performing a baseline psychological profile prior to major cardiac surgery with continued 
evaluation through the post-operative period. This information may assist in identifying 
pre-operative characteristics of danger or opportunity that may affect patient outcomes 
(McCormick et al., 2006; Mishel, 1988). 
  Magni and colleagues (1987) conducted a prospective study, which revealed 
those patients with a higher psychological distress score prior to cardiac surgery were 
more likely to have higher scores on depression and anxiety one year after surgery. 
Ninety-nine patients were followed over the course of one year after their cardiac 
surgery.   Approximately 25% of patients had continued symptom distress, high scores on 
anxiety and depression scales, at one year after surgery.  These researchers also relayed 
the importance of the need for further preoperative evaluation and support prior to 
revascularization.  Similarly, Frasure-Smith and colleagues (1993) reported an increased 
mortality among patients who were depressed at time of a cardiovascular event 
(Rumsfeld & Ho, 2005).  
  11 
Another research study, nine hundred and sixty three patients requiring coronary 
artery bypass graft  (CABG) were found to have higher scores of depression that 
translated into negative health outcomes after 6 months (Mallik et al., 2005). Patients 
underwent a baseline evaluation of both physical and psychological status prior to their 
scheduled procedure followed by an assessment utilizing a depression scale post-
operatively.  In this study, depression was characterized as an independent risk factor of 
poor health outcomes six months after coronary artery bypass surgery; demonstrating that 
depressive symptoms were a better measure of surgical health outcomes than co-
morbidity factors such as left ventricular function, diabetes mellitus, heart failure, and 
myocardial infarction (Mallik et al., 2005).   
Clearly, studies have shown the link between these pre-operative factors specific 
to stress of illness, uncertainty, and pre-operative depression and the overall quality of 
life of patients' post-operatively.  These types of stressors, which can result in a life style 
change or modification, can trigger a depressive response.  The adaptive or maladaptive 
response of the patient to the cardiac surgical procedure was the focus in addressing the 
problem and improving patient outcomes (Lauermann, 2000).   
In 2011, Seriani discussed the diathesis-stress model of depression relating the 
genetic and biochemical (diathesis) individual response to stressful event.  This 
relationship may consider the effect of uncertainty, baseline evaluation of depression, and 
the neurotransmitter serotonin in the pre-operative phase before cardiac surgery.  
Depression 
 
The common feature of all depressive disorders is the presence of sad, empty, or 
irritable mood, accompanied by somatic and cognitive changes that significantly affect 
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the individual’s capacity to function (APA-5, 2013, p. 155).  The American Psychiatric 
Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria is 
designed to be utilized by clinicians to assist in a more reliable diagnosis of mental 
disorders (2013).  The DSM-5 assists in delineating depressive disorders based on 
symptoms that may limit a person's functional capacity. A sub-category of major 
depressive disorder labeled Depressive Disorder Due to Another Medical Condition 
allows for a consideration of symptoms and associated factors related to the specific 
episodes along with a timeline for evaluation (APA-5, 2013). A thorough assessment of a 
patient’s history of depression is warranted when determining their status related to 
depression at the time of cardiac surgery.  
 In a study by the Centers for Disease Control (2010), the World Health 
Organization in 2004 reported depression as the third leading cause of disability in higher 
income countries (USDOH, 2010).  Similarly, in 2009, the Annals of Internal Medicine 
employed a task force, which revealed consistent findings labeling depression among the 
leading causes of disability in persons age 15 and older (US Preventive Task Force, 
2009).  The National Institute of Mental Health (NIMH) estimates that 1 to 5% of older 
adults experience depression and that number rises to 11.5% for hospitalized patients.  
Further data revealed that in 2012, an estimated 16 million adults (age 18 or older) 
experienced one major depressive episode; this accounts for 6.9% of all adults in the 
United States (NIMH, 2012).  Early recognition and treatment play an integral role in 
overall patient health and outcomes. 
Depression has been well documented when viewed within the context of medical 
healthcare with its effects on outcomes.  Research is ongoing looking at underlying 
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causes of depression and its association with medical conditions.  Symptoms typically 
associated with depression such as sadness, anxiety, fear, and loss of control are among 
the clinical signs either voiced or silenced by depression.  Narrowing the focus of post-
operative depression to its significance within the cardiac population demonstrated the 
interrelatedness of pre-operative evaluation and its association post-operatively in 
patients receiving cardiac care and undergoing cardiac revascularization (Gallagher & 
McKinley, 2009; Mallik et al., 2005; Peterson et al., 2002; Timberlake et al., 1997; Tully 
et al., 2009).  Factors such as social support, psychological baseline, and physical 
response to the post-operative state play a role beginning at initial diagnosis through 
cardiac recovery and after care.   
The Beck Depression Inventory (BDI) is a 21-question multiple-choice inventory 
that can be completed by the patient or by the clinician. The BDI is among the most 
widely used instruments for measuring the severity of depressive symptoms. The tool is 
designed for individuals 13 and older, with items relating to symptoms of depression 
including hopelessness and irritability, thought processes such as guilt or feelings of 
being punished, physical fatigue, weight loss or gain, and lack of interest in sexual 
activity.  It utilizes evaluation of depressive symptomology with each category 
representing a specific expression of depressive behavior (Beck, 1972). 
There is ample research and clinical evidence that the effects of illness on an 
individual may have undesirable consequences.  Further areas of interest for exploration 
are the possible connection between pre-operative uncertainty in illness utilizing the 
theoretical framework established by Mishel; depression, measured by the Beck 
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Depression Inventory; and the measurement of serotonin levels within the cardiac surgery 
population.   
Serotonin 
 
In addressing potential causes of depression, the effect of serotonin, a 
neurotransmitter, emerged as a potential correlate to the diagnosis of depression.  Much 
of the research related to serotonin as a direct contributor has been controversial; centered 
mainly on therapeutic treatment options after the diagnosis. The role serotonin levels may 
play in identifying those individuals at greater risk for depression related to illness or 
surgery is worthy of further exploration.  A review of the literature examined both 
scientific details of the workings of serotonin as a neurotransmitter in the body as well as 
associated research studies that have investigated the measurement of serotonin levels 
and depressive symptoms within certain disease processes. 
A person's genetic makeup coupled with the advent of a stressful situation has 
been linked with increased risk of depression.  Each person is uniquely different in his or 
her truest form; abnormalities within this genetic makeup have been cause for 
investigation into the manifestations of one's behavior.  The available amount of 
neurotransmitter within the synapses of certain areas of the brain makes a difference in 
expression of behavior.  Genetic mutations of the serotonin molecule, called 
polymorphisms, are reflected in the gene description of the short or ‘s’ allele or the long 
‘l’ allele where alleles represent different forms of the gene that can lead to variations in 
the structure of the protein resulting in changes in transmission of information (Medina, 
2004, p. 18). 
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Elder and Mosack (2011) define and discuss important concepts in developing a 
basic understanding of genetics and depression.  Hereditability is the amount of variation 
of a trait that can be attributed to genetic influences.  Evidence has been presented linking 
individuals with the s allele as being at greater risk of developing depression related to 
environmental influences than those without this particular allele.  If an individual carries 
either one s allele or two, the risk of major depressive disorder is greater (Elder & 
Mosack, 2011).  
The role of neurotransmitters and their receptors play an integral role in areas 
related to brain activity and the body's response.  This intricate network within the brain 
is responsible for maintaining homeostasis of neurologic activity throughout the body.  
Serotonin (5-HT) is discussed due to its association with behavior disorders at lower and 
higher levels ranging between depression and anxiety (Blows, 2000).  5-HTT, the 
serotonin transporter protein was reviewed related to its involvement in the transport and 
reuptake of serotonin.  This information provided insight into the role of serotonin and its 
use in conjunction with psychometric tools to assist in the early identification of those 
patients at risk for post-operative depression in the cardiac surgical population. 
Serotonin (5-HT) is important for its role in the cognitive and affective behaviors 
of mood, sleep, appetite, and body system functions.  It is part of the amine group of 
neurotransmitters found within the raphe nuclei on the pons, medulla, and the brain stem 
(Blows, 2000; Valenzuela, Puglia, & Zucca, 2011) .  The serotonin pathway leads to 
neuronal pathways within our body with distribution areas in "multiple centers of the 
cerebrum, the limbic area, and the basal ganglia" (Blows, 2000, p. 234). 
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Serotonin is classified as a monoamine.  An associated monoamine theory of 
depression, first discussed forty years ago, hypothesizes this link between decreased 
levels of circulating serotonergic activity as a causative factor related to depression 
(Sanner & Frazier, 2011)  
 Blows (2000) discusses the production of serotonin from the amino acid, 
tryptophan, which can be found in dietary sources.  The passing of tryptophan through 
the blood brain barrier and its conversion to serotonin relies on the enzymatic processes 
occurring within the neuronal pathways.  Deficiency in any of the vitamins that aid in the 
conversion may cause changes in behavior (Medina, 2004).  Sanner and Franzier (2011) 
relate factors that may be a resultant cause of the deficiency; these include dietary 
depletion of tryptophan, inhibition of enzymatic processes of conversion, decrease in 
serotonin receptors or a non-working transport system.  The 5-HT receptor sites and their 
pre-synaptic and post-synaptic function play an important role within these transport 
systems.  The conversion process in which tryptophan is converted to 5-HT with 
subsequent metabolism allows for 5-HTT to perform as the transporter protein.   
The 5-HTT gene is the transport protein for serotonin.  It plays an essential part in 
"regulating the concentration of serotonin in the brain" (Medina, 2004, p. 17).  The role 
of 5-HTT is in the reuptake of serotonin in the cell thereby maintaining a state of 
concentrated equilibrium that allows for expression of the gene.  
Figure 1.  Represents the activity within the transport system where serotonin is 
being released by the pre-synaptic area and binding with the receptors in the postsynaptic 
cells.  It appears that any factor that may alter the course of activity via transport or 
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uptake would have an effect on the circulating levels of serotonin resulting in a potential 
change in behavior.   
Figure 1. Action of Serotonin and the Serotonin Transporter.  
 
Schematic drawing of the neurotransmitter serotonin being released from the presynaptic 
cell and binding to the receptors on the postsynaptic cell. 5-HTT encodes the protein 
labeled reuptake transporter. Image from https://dynamichealthresources.com. Permission 
granted by Dynamic Health Resources. 
 
This information assisted in providing insight into the effect that serotonin has on 
individual behavior.  Baseline psychosocial evaluation along with serotonin levels in the 
pre-operative phase may assist in identifying those at increased risk; individuals that may 
be on the cusp of uncertainty and depression before cardiac revascularization. 
The cumulative result of the information provided within the review revealed 
components that may have an effect on the overall health outcomes of those individuals 
undergoing cardiac surgery.  Further research into the components of uncertainty, 
depression, and serotonin level may lead the nursing health care team into strategic 
development of pre-operative tools to assist with early detection and intervention. These 
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areas were further explored to gain information and impart knowledge to improve health 
outcomes in this population. 
 Current practice guidelines and clinical pathways do not proactively assess 
patients who are awaiting surgery for history of depression or uncertainty.  This accounts 
for a missed opportunity for early identification, education, and intervention (Blumenthal 
et al., 2003; Lett et al., 2004; Pignay-Demaria et al., 2003).   There is no measurement 
tool in use pre-operatively to gauge those patients at potential risk for poor psychological 
outcomes after surgery, thereby affecting post-operative recovery and quality of life.   
Nursing Implications  
Evidence Based Screening and Assessment 
Presently, most health care clinicians do not perform a focused assessment of the 
patient related to their psychological well-being with consideration to factors that may 
influence their recovery.  Within the cardiac surgery population, there is no established 
standard of care or core measure, which assesses the pre-cardiac surgery patients with 
regard to risk for depression post-surgery.  Because there are no established parameters 
for this particular assessment, the exploration of influencing factors was the focus of 
further investigation.   
Call for Research 
Current practice guidelines and clinical pathways do not proactively assess 
patients who are awaiting surgery for history of depression or uncertainty.  Gallagher and 
McKinley (2009) discussed the need for a more proficient method of assessment and 
identification of psychological symptoms in this patient population that may affect 
outcomes.  Not establishing guidelines for assessment and treatment of psychological 
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symptoms transpires into a missed opportunity for early identification, education, and 
intervention (Blumenthal et al., 2003; Lett et al., 2004; Pignay-Demaria et al., 2003).  
There is no standard measurement tool in use pre-operatively to gauge those patients at 
potential risk for poor psychological outcomes after surgery, thereby affecting post-
operative recovery and quality of life.   Panagopoulou and colleagues (2005) found that 
those individuals with psychological risk prior to cardiac surgery had worse health 
outcomes in the post-operative time period at one month and six months (Panagopoulou, 
Montgomery, & Benos, 2006). This finding speaks to the need to explore opportunities 
for risk stratification or modification within this population. 
Summary 
The number of coronary artery bypass graftings (CABG) in the United States, 
according to data from 2010, was approximately 395,000 not including valve procedures, 
or valve procedures plus CABG (www.cdc.gov).  This information coupled with the 
literature that supports the evidence of depression in this population of patients presented 
an opportunity for further exploration into the role of pre-operative evaluation of 
uncertainty, depression and serotonin.  Uncertainty, as discussed through the theoretical 
framework of Mishel, seeks to establish whether the patient views illness as a danger or 
opportunity. This information may assist in determining an individual's adaptation to 
illness.  The BDI assesses severity of depressive symptoms by reviewing patient 
responses at the particular point in time in which the BDI is completed.  The use of both 
of these tools offers valuable information that in conjunction with the biomarker measure 
of serotonin may assist in the development of a standard of care to recognize early signs 
and symptoms pre-operatively. This pre-operative evaluation may include nursing as an 
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important link in identifying those at risk, informing the health care team, and working on 
interventional strategies to promote positive health outcomes. 
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CHAPTER THREE 
Research Design 
A descriptive, correlational, prospective design was used to conduct this study. 
The relationships among specific variables as associative factors related to post-operative 
depression were explored.  The importance of this study lies in the fact that at present, 
there is no standard of care in the evaluation of depressive symptoms as well as 
uncertainty in the cardiac surgical population pre-operatively and post-operatively.   
This study examined depression scores with the use of the Beck Depression 
Inventory (BDI), levels of uncertainty as measured by Mishel's Uncertainty in Illness 
Scale (MUIS), along with the measurement of serotonin level, a neurotransmitter in the 
brain.  These variables were explored relative to their impact on post-operative 
depression in patients undergoing cardiac surgery using a descriptive, correlational, 
prospective design.   
Setting 
 
The setting was the outpatient Cardiovascular Surgery Department at the 
University of Pennsylvania-Presbyterian Hospital in Philadelphia, Pennsylvania.  The 
practice consults with more than 150 patients per month including pre-operative and 
postoperative patients.  These numbers yield an elective surgical population of 50-72 
surgeries per month. 
Population  
 
The population under study included participants undergoing elective cardiac 
surgical procedures for symptoms related to coronary artery disease and/or valvular heart 
disease. The inclusion criteria included men and women age 21 or older requiring cardiac 
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surgery; with no exclusions related to ethnicity, race, or religion. Exclusion criteria 
included those with a diagnosis of mental disorder, anti-depressant therapy, non-English 
speaking persons, and those diagnosed with a mental handicap.   
Power Analysis 
 
No previous research was conducted using the combination of variables explored, 
therefore, the two-tailed significance criteria was set at 0.05 and the power at .80. The 
results for the projected sample size that could achieve these criteria was 52 participants.  
Measurements  
 
Demographics 
 
Demographic data including type of surgical procedure, gender, age, marital 
status, years of education, annual household income, history of depression, history of 
certain types cancer were collected (Appendix A). Variables measured included 
depressive symptomatology, levels of uncertainty, and serotonin levels. The predictor 
variables were uncertainty, depression and serotonin.  The outcome variable was 
depression. 
Beck's Depression Inventory (BDI)  
 
The BDI (Appendix B) was utilized for the evaluation of depressive 
symptomology.  Permission for use was granted through the American Psychological 
Association (APA), which owns the copyright to the original scale.  The BDI is based on 
categories of symptoms and attitudes (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961).  
Each category represents a specific expression of a depressive behavior.  Behavior 
responses were scored on a self-report scale.  The 21-question inventory had a maximum 
score of 63 and a minimum of zero.  Depression scores were classified based on specific 
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parameters established within the BDI.  Higher-level scores reflected greater depressive 
symptoms.  These ranges reflected mild (11-16), moderate (21-30), severe (31-40), and 
over 40 classified as severe depression. Scores above 17 reflected a correlation with 
depressive symptoms that would require medical treatment. Beck and colleagues (1961) 
in their original work established reliability and validity through their administration of 
the scale and clinical acumen.  The BDI has established itself as a reliable and valid 
standardized measure of assessment of depressive symptoms within a variety of 
populations.  For example, many studies of post-operative outcomes for depression were 
evaluated using the BDI in a population of cardiac patients who had undergone CABG 
(Connerney, Sloan, Shapiro, Bagiella, & Seckman, 2010; Foss-Nieradko, Stepnowska, & 
Piotrowicz, 2012; King, Colella, Faris, & Thompson, 2009) 
The BDI was administered to the participant after informed consent had been 
obtained.  This was a paper and pencil collection method with the questionnaire taking 
approximately 15 minutes to complete. An initial assessment was obtained on the 
scheduled day of pre-operative instruction and testing for the participant. Data were 
entered into a computer data system under the participant number for statistical analysis.  
Further administration of the tool took place at 4 weeks and 12 weeks post-operatively.   
Mishel's Uncertainty in Illness Scale (MUIS)  
The MUIS (Appendix C) was used to measure uncertainty in this population.  The 
scale is based on her theory developed in 1981, which corresponds to an individual's 
adaptability to a diagnosis of illness and how the individual interprets and integrates this 
information.  Uncertainty related to an illness may have a negative trajectory with 
physical and psychological effects on both the patient and the recovery process.  MUIS, a 
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structured, self-administered tool, was utilized in the quantitative evaluation of 
participant responses related to illness.  Based on a thirty-three question Likert scale, 
scores were analyzed on uncertainty related to "recognition, accommodation, and 
perception” (Mishel, 1982, p.259). In a previous study in a sample of forty-two patients 
undergoing elective CABG surgery, uncertainty measurements for those patients awaiting 
surgery were at moderate levels with an associated decrease in quality of life 
(McCormick et al., 2006). Similarly, uncertainty and quality of life examined both pre 
and post coronary angiography at one year revealed that baseline uncertainty affected 
patient quality of life (Eastwood et al., 2008). 
Permission (Appendix D) was obtained from Dr. Merle Mishel for use of her 
scale in this research study.  The Adult Form of the MUIS had explicit instructions 
guiding the participant to evaluate how they were feeling on the particular day in which 
they were responding to the questionnaire.  The scale required a response to each 
question.  The 5-point Likert format ranges from (0) strongly disagree to (5) strongly 
agree.  Cumulative scores obtained through the questionnaire ranged from 0-165, with 
higher scores indicating greater uncertainty.  Cumulative numerical scores corresponded 
to mild (0-54), moderate (55-110), and high (111-165) levels of uncertainty. 
A detailed report of the work conducted using the scale, including its reliability 
and consistency in different patient populations is offered in the tool's manual. The scale 
has many different forms and is used internationally in a wide variety of disease 
processes.  The adult form, looking at the cardiac population, in terms of reliabilities and 
Coefficient Alpha for categories of ambiguity, complexity, inconsistency, and 
unpredictability within the questionnaire were in the range of 0.73-0.93 overall (Mishel 
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Manual). The questionnaire related to uncertainty in illness (MUIS) was administered by 
paper and pencil method to the patient at each established time point. Overall, total scores 
on the MUIS were utilized in the data analyses.  
Serotonin 
 
 This neurotransmitter and biomarker, was collected via a blood sample at the 
time of patient's routine pre-operative blood work.  Approximately, 4 ml of blood was 
drawn in a separate tube with preservative added to ensure stability of the specimen.  The 
blood specimen was identified with the participant study number.  No identifying 
information was labeled on the specimen.  Specimens were discarded at the conclusion of 
the study by reference laboratory staff.  These specimens were sent to ARUP, a national 
reference laboratory, for analysis.  The reference range utilized by the lab was 50-220. 
The results of the blood studies were categorized as nominal data with scores falling 
within a range of low to high based on the parameters established by the lab.   
Research Procedure 
 
Once approvals from the appropriate Institutional Review Boards were obtained, 
recruitment activities began.  Participants who met the inclusion criteria were identified 
through the cardiovascular office staff and surgeons within the department.  Once 
identified, the study was explained and the patient's interest in participation was 
determined.  Reassurance in the privacy and confidentiality of all matters related to the 
study were clearly outlined in the consent for participation. Participants were identified 
on all forms throughout the study by number only.   Participants were asked to provide 
their address for future mailings related to the research study.  Specific identifying 
numbers correlated name and address for the purpose of this future communication. 
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Participants were asked their preferred method of communication, via telephone or email, 
for follow-up with questionnaires if needed. Participants were not identified by name in 
any reports within the study. Participants were informed that they may withdraw from the 
study at any time and that any data collected to that point would be destroyed. 
Patients scheduled for coronary artery bypass grafting, valve replacement, or both 
bypass grafting and valve replacement were identified as potential participants through 
the Cardiovascular Surgery Department. Upon meeting with the cardiovascular surgeon 
in consult, the opportunity to participate in the study was discussed with the patient by 
the surgeon.  If the patient was agreeable to receive further information, this primary 
researcher or a research assistant was on hand to provide a detailed description of the 
study and answer any questions related to participation.   
Data were gathered at set intervals established prior to the initiation of the study 
corresponding to the pre-operative phase, 4 weeks post-operatively, and 12 weeks post-
operatively.  Preoperative data were collected in the physician’s office in the surgical 
department. Surveys were distributed to participants at 4 weeks and 12 weeks after 
surgery, the 4 week surveys were either mailed back or brought with them to their four-
week post-operative visit. The twelve-week survey was mailed back by the patient, as 
there was no in-person visit. Blood samples were collected in the outpatient lab center 
both preoperatively and at four weeks to determine serotonin levels. Patients did not 
return for in-person twelve-week visits, therefore serotonin levels could not be evaluated 
at this time point. 
A research assistant was available to review the details of the study with each 
participant. This informational process took approximately 15 minutes.  If the patient 
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agreed to participate in the study, the nurse practitioner working in the physician’s office 
then met with the participant and obtained informed consent (Appendix E). The 
demographic data sheet, the BDI, and the MUIS were explained to the participant and 
then administered by the nurse practitioner. The surgical date was then agreed upon by 
the patient and the surgeon.  
The average time for completion of the demographic data and the two scales was 
approximately 30 minutes.  Data were entered into a computer data system under the 
participant number for statistical analysis.   
After discharge from the hospital, questionnaires were sent to the participant at 
home for completion with return postage guaranteed via USPS Priority Mail.  Once the 
follow-up questionnaires were returned, questionnaires were stored in a locked cabinet 
and data were entered into a software program for statistical analysis on a password-
protected computer. 
A sample of blood to measure serotonin was obtained at the same time that 
standard pre-operative blood work as required by the hospital was collected by drawing 
an extra tube of blood from the patient, Blood specimens were sent by the University of 
Pennsylvania Hospital to ARUP, the off-site reference laboratory, for analysis through a 
specific research protocol. ARUP, the reference lab, was the designated off-site 
laboratory that conducted this specific test.  Serotonin levels were measured by high-
pressure liquid chromatography.  A serum separator tube was used for collection.  The 
cost to run this test was incurred by the primary research team. The expense through 
ARUP was $40.00 per specimen. This was the first of two blood draws required as part of 
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the research study.  The second blood draw at 4-weeks post-operative was drawn and 
analyzed in the same way as the first blood draw. 
Data Analysis 
 
Data screening in this research analysis played an integral role in the accuracy of 
the reported data results.  Tabachnik and Fidell (2013) discussed the importance of 
identification and resolution of factors that may produce erroneous results.  Initially, a 
thorough review of completed demographic data and the two surveys collected was done 
prior to its inclusion in the database. An individual on the research team with data entry 
experience then checked and cleaned the data set.  Missing data were assessed and 
consideration was given to factors that could reveal an arbitrary link or particular pattern 
within the data set.  The final database was reviewed with the statistician to determine 
that data were entered properly and that missing data was handled properly. 
 Contact information was obtained to enable the research assistant to communicate 
with the participant at the designated time intervals if questionnaire data had not been 
returned.  If participant wished results of the study, they were to contact the primary 
researcher. 
IBM SPSS Version 23 was used for analysis of the data.  Descriptive statistics 
were run on all variables, including frequencies and central tendencies of the variables of 
depression, uncertainty in illness, and serotonin with consideration of the dependent 
variable of depression scores. This information determined means and standard 
deviations for each predictor.  Analysis also revealed the significant bivariate correlations 
within the data set.   
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To assure the integrity of the analysis, assumptions for multiple regression 
analyses were tested.  Only those predictors that had relationships with the outcome were 
included in the model.  Data were tested and met the assumptions of normal distribution.  
Tolerance values for all predictors were greater than 1-R² indicating that the assumption 
of no multicollinearity between the predictor variables was not violated.  Adequate 
sample size would decrease the risk of Type II error.  Multivariate linearity was assessed 
identifying the relationship between depression scores and the variables of uncertainty 
and serotonin. 
Multiple regression analyses were used to determine if a relationship exists 
between the pre-operative measurements of depression, uncertainty in illness, and 
serotonin levels with the occurrence of post-operative depression in cardiac-surgical 
patients.  The independent variables including depression, uncertainty, and serotonin 
were evaluated utilizing the tools previously discussed.   Depression scores were 
classified based on the specific parameters established within the BDI guidelines.  
Cumulative scores for the Uncertainty in Illness scale were obtained through Likert scale 
format.  In addition, serotonin levels were interpreted using nominal scores according to 
specific parameters identified by the laboratory.  
Timeline 
 
The recruitment phase took place over the course of approximately four months.   
Collection of data at specified intervals lasted 12 weeks' time.  Data entry was ongoing 
through the research process.  Once all data were collected, analysis of data and 
interpretation of statistical results were conducted.  Dissemination of results will 
conclude with dissertation and manuscript submission of results of this study. 
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Protection of Research Participants 
 
IRB approvals were obtained prior to the initiation of the study.  Participants’ 
privacy and confidentiality were upheld at all times. All data collected from participants 
were stored in a locked filing cabinet in the primary investigator’s office. Human subjects 
were involved in recruitment and enrollment for this research study.  Informed consent 
was explained to the participants. Those who wished to participate signed the consent 
form and a copy was given to them. Participation in this study was voluntary.  
Participants could leave the study at any time for any reason without specification. 
Participating in this study had minimal risk but no greater than every day activities.  It is 
also important to note that an additional tube of blood was drawn along with the standard 
preoperative blood work required by the hospital for the first blood specimen required for 
this study. Therefore, participants did not need to experience any additional and/or 
potential discomfort associated with blood draws. The second specimen of blood 
obtained at the 4-week post-operative visit did require a blood draw. 
Access to information related to this research study was limited to the principal 
investigator, research assistant, and the research chair affiliated with the University. 
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Demographic Questionnaire 
ID # 
1.Scheduled Procedure: 
CABG 
CABG plus Valve 
Valve Surgery Only 
2. Gender             
a) Male                  
b) Female 
3. Age 
4. Marital Status    
a) Single                               b) Married                                   c) Divorced 
d) Widow/Widower              e) Separated                                 f) Living with significant 
other 
5. Years of Education 
a) Some High School or less 
b) High School graduate 
c) Some college or associate degree 
d) College graduate/Bachelor's degree 
e) Post graduate/professional degree 
Annual Household Income 
a) Under $15,000 
b) $15,000-$24,999 
c) $25,000-$34,999 
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d) $35,000-$49,999 
e) $50,000-$74,999 
f) $75,000-$99,999 
g) $100,000 and over 
Previous episodes of depression:  Yes               No 
Are you presently taking any anti-depressant medications?   Yes      No 
 If yes, please list._______________________________________ 
Do you have any history of stomach cancer or thyroid cancer?  Yes    No 
 If yes, please explain. _____________________________________ 
Do you have any history of psychological disorders?   Yes    No 
 If yes, please explain. ____________________________________ 
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Beck Depression Inventory (BDI) 
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Beck Depression Inventory 
Please select the response that most closely states how you are feeling at the present time. 
1. 
 0 I do not feel sad. 
 1 I feel blue or sad. 
 2  I am blue or sad all the time and I can't snap out of it. 
 3 I am so sad and unhappy that I can't stand it. 
2. 
 0  I am not particularly pessimistic or discouraged about the future. 
1 I feel discouraged about the future. 
2 I feel I have nothing to look forward to. 
3 I feel the future is hopeless and that things cannot improve. 
 
3. 
 0 I do not feel like a failure. 
 1 I feel that I have failed more than the average person. 
2 I feel that I have accomplished very little that is worthwhile or that means 
anything. 
 3 I feel I am a complete failure as a person. 
4. 
 0 I am not particularly dissatisfied. 
 1 I don't enjoy things the way I used to. 
 2 I don't get satisfaction out of anything anymore. 
 3 I am dissatisfied with everything. 
 
5. 
 0 I don't feel particularly guilty. 
 1 I feel bad or unworthy a good part of the time. 
 2 I feel quite guilty. 
 3 I feel as though I am very bad or worthless. 
6. 
 0 I don't feel I am being punished 
 1 I have a feeling that something bad may happen to me. 
 2 I feel I am being punished or will be punished. 
 3 I feel I deserve to be punished. 
7. 
 0 I don't feel disappointed in myself. 
 1 I am disappointed in myself. 
 2 I am disgusted with myself. 
 3 I hate myself. 
8. 
 0 I don't feel I am any worse than anybody else. 
 1 I am critical of myself for my weaknesses or mistakes. 
 2 I blame myself for everything that goes wrong. 
 3 I feel I have many bad faults. 
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9. 
 0 I don't have any thoughts of harming myself. 
 1 I have thoughts of harming myself, but I would not carry them out. 
 2 I have definite plans about committing suicide. 
 3 I would kill myself if I could. 
10.  
0 I don't cry any more than usual. 
1 I cry more now than I used to. 
2 I cry all the time now, I can't stop it. 
3 I used to be able to cry but now I can't cry at all even though I want to. 
11. 
 0 I am no more irritated now than I ever am. 
 1 I get annoyed or irritated more easily than I used to. 
 2 I feel irritated all the time. 
 3 I don't irritated at all at the things that used to irritate me 
12. 
 0 I have not lost interest in other people. 
 1 I am less interested in other people now that I used to be. 
 2 I have lost most of my interest in other people and have little feeling for 
 them. 
 3 I have lost all my interest in other people and don't care about them at all. 
13. 
 0 I make decisions about as well as ever. 
 1 I am less sure of myself now and try to put off making decisions. 
 2 I can't make decisions any more without help. 
 3 I can't make decisions at all any more. 
14. 
 0 I don't feel I look any worse than I used to. 
 1 I am worried that I am looking old or unattractive. 
2 I feel that there are permanent changes in my appearance and they make 
me look unattractive. 
3 I feel that I am ugly. 
15. 
 0 I can work about as well as before. 
 1 It takes extra effort to get started at doing something. 
 2 I have to push myself very hard to do anything. 
 3 I can't do any work at all. 
16. 
 0 I can sleep as well as usual. 
 1 I wake up more tired in the morning that I used to. 
 2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep. 
 3 I wake up early every day and can't get more than 5 hours sleep. 
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17. 
 0 I don't get any more tired than usual. 
 1 I get tired more easily than I used to. 
 2 I get tired from doing anything. 
 3 I get too tired to do anything. 
18. 
 0 My appetite is no worse than usual. 
 1 My appetite is not as good as it used to be. 
 2 My appetite is much worse now. 
 3 I have no appetite at all any more. 
19. 
 0  I haven't lost much weight, if any, lately. 
1 I have lost more than 5 pounds. 
2 I have lost more than 10 pounds. 
3 I have lost more than 15 pounds. 
20. 
 0 I am no more concerned about my health than usual. 
1 I am concerned about aches and pains or upset stomach or constipation or 
other unpleasant feelings in my body. 
2 I am so concerned with how I feel or what I feel that its' hard to think of 
much else. 
3 I am completely absorbed in what I feel. 
21. 
 0 I have not noticed any recent change in my interest in sex. 
 1 I am less interested in sex than I used to be. 
 2 I am much less interested in sex now. 
 3 I have lost interest in sex completely. 
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Mishel Uncertainty in Illness Scale – Adult Form 
 
Instructions 
          Please read each statement. Take your time and think about what each statement  
          says. Then place a “X” under the column that most closely measures how you  
          are feeling  TODAY. If you agree with a statement, then you would mark under 
          either “Strongly Agree” or “Agree”. If you disagree with a statement, then mark  
          under either “Strongly Disagree” or “Disagree”. If you are undecided about how  
          you feel, then mark under “Undecided” for that statement. Please respond to every  
          statement. 
 
1. I don’t know what is wrong with me. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
2. I have a lot of questions without answers. 
  
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
3. I am unsure if my illness is getting better or worse. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
4.  It is unclear how bad my pain will be. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______            ______          ______            ______                 ______ 
5.   The explanations they give about my condition seem hazy to me. 
 Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                    (4)                 (3)                    (2)                        (1) 
     _______            ______          ______            ______                 ______ 
 
 6.    The purpose of each treatment is clear to me. 
  Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
             (5)                  (4)                 (3)                    (2)                        (1) 
         _______         ______          ______            ______                 ______ 
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 7.    When I have pain, I know what this means about my condition. 
   Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
              (5)                  (4)                 (3)                    (2)                        (1) 
          _______         ______          ______            ______                 ______ 
 
  8.    I do not know when to expect things will be done to me. 
   Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
              (5)                 (4)                 (3)                    (2)                        (1) 
 
         _______         ______          ______            ______                 ______ 
 
   9.   My symptoms continue to change unpredictably. 
   Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
              (5)                 (4)                 (3)                    (2)                        (1) 
          _______        ______          ______            ______                 ______ 
 
10.  I understand everything explained to me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
 11.  The doctors say things to me that could have many meanings. 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
   
12.  I can predict how long my illness will last. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
     
13. My treatment is too complex to figure out. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
14. It is difficult to know if the treatments or medications I am getting are helping.  
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
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15. There are so many different types of staff; it’s unclear who is responsible for 
what. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
16. Because of the unpredictability of my illness, I cannot plan for the future. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
17. The course of my illness keeps changing. I have good and bad days. 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
18. It’s vague to me how I will manage my care after I leave the hospital. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
19. I have been given many differing opinions about what is wrong with me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
20. It is not clear what is going to happen to me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
21. I usually know if I am going to have a good or bad day. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
22. The results of my tests are inconsistent. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
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23.  The effectiveness of the treatment is undetermined. 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
24. It is difficult to determine how long it will be before I can care for myself.  
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
25. I can generally predict the course of my illness. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
26. Because of the treatment, what I can do and cannot do keeps changing. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
27. I’m certain they will not find anything else wrong with me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
28. The treatment I am receiving has a known probability of success. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
29.  They have not given me a specific diagnosis. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
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30. My physical distress is predictable; I know when it is going to get better or worse. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
31. I can depend on the nurses to be there when I need them. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
 
32. The seriousness of my illness has been determined. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
 
33. The doctors and nurses use everyday language so I can understand what they are 
saying. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
           _______         ______          ______            ______                 ______ 
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